I can tell you from listening to other conference calls (biotech and otherwise) that what she's doing is not standard and it raises red flags to big investors.
Other CEOs say all the time, "I can't answer that question because of _________", and they give the reason. Why can't she? Instead she won't take questions.
People want large, credible investment firms to cover the stock - I guarantee you that they aren't going to do it with her spoon feeding people selected information.
News 
Market Data 
Discover 
AI
